Showing results (51-60 of 57) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Annals of Surgery|June 16, 2023
Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From 1462 Patients on the Prospective, Randomized I-SPY2 TrialRita A Mukhtar, Harrison Chau, Hannah Woriax, et al.BMJ (Clinical Research Ed.)|August 21, 2020
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trialJayant S Vaidya, Max Bulsara, Michael Baum, et al.JAMA Oncology|April 3, 2020
Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival: Long-term Results From the TARGIT-A Randomized Clinical Trial in Early Breast CancerJayant S Vaidya, Max Bulsara, Christobel Saunders, et al.British Journal of Cancer|May 26, 2021
New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancerJayant S Vaidya, Max Bulsara, Michael Baum, et al.Annals of Surgical Oncology|July 23, 2025
Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 TrialMandeep Kaur, Katrina Dimitroff, Judy C Boughey, et al.The Lancet. Oncology|December 25, 2025
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort studyGiacomo Montagna, Michael Alvarado, Sara Myers, et al.Nature Communications|November 6, 2021
Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2<sup>+</sup> breast cancer in the adaptively randomized I-SPY2 trialAmy S Clark, Christina Yau, Denise M Wolf, et al.Pageof 6